Ph.D, Chief Business Officer
Joe joined Edelris in January 2025 as Chief Business Officer. Prior to Edelris, he worked for 13 years in the CRO industry in positions spanning Operations, Management, and Sales, including 8 years as head of Business Development at SOLVO Biotechnology. Subsequently, following the acquisition of SOLVO by Charles River Laboratories, he led Charles River’s global DMPK and in vitro ADME Business Development team.
Joe holds a Ph.D. in Membrane Protein Biochemistry from Imperial College London and has worked as a post-doc at the University of Washington in the Depts of Pharmaceutics and Medicinal Chemistry (Prof. J. Unadkat & Prof. W. Atkins), as well as at Queen Mary University of London (Prof. K Linton) and the Biozentrum, University of Basel (Prof. Anna Seelig).
“The team at Edelris excels in providing the highest quality leads, which stems from our years of experience, flexibility, creativity, and unwavering commitment to science. As a result, our clients can be confident that by partnering with Edelris they will position their drug discovery programs for future success.”